The medical nutrition market in the United Kingdom is showing steady growth amid an ageing population, an increase in the prevalence of chronic diseases, and growing attention to nutritional support in clinical practice. Medical or clinical nutrition includes specialised mixtures, drinks and formulas used for patients at risk of malnutrition, after surgery, during cancer treatment, for neurological disorders and other conditions where a normal diet is insufficient. In the UK, this segment is gradually moving beyond hospitals and becoming available for outpatient care and home use.
One notable example of a popular product in this segment is Fresubin, a specialised nutrition product widely used to support patients with increased calorie and protein requirements. Demand for such products is increasingly being met through online channels, opening up significant opportunities for e-commerce and pharmacy platforms.
Market growth factors in the UK
The UK has one of the most developed healthcare systems in Europe, where nutritional support is integrated into clinical protocols. Several key factors can be identified among the main drivers of growth.
Firstly, the demographic factor. The proportion of people aged 65+ is steadily increasing. Elderly patients are more likely to face the risk of weight loss, sarcopenia and weakened immunity, which increases the need for high-calorie and protein mixtures.
Secondly, the increase in chronic diseases. Oncology, diabetes, cardiovascular diseases and gastroenterological disorders require a comprehensive approach to treatment, where nutrition plays an important role.
Thirdly, the development of home care. The healthcare system is increasingly transferring patients undergoing long-term treatment to outpatient care. This stimulates demand for convenient formats of medical nutrition for use at home.
Changing consumer behaviour and digitalisation
After the COVID-19 pandemic, online shopping has become a common channel of purchase even for categories that were previously associated exclusively with offline pharmacies. Medical nutrition is no exception. Patients and their families want quick access to products, the ability to compare prices and learn about characteristics without having to visit multiple pharmacies.
Digital platforms provide:
- convenient search for specialised formulas;
- detailed description of composition and indications;
- home delivery;
- subscription models for regular supplies;
- price transparency.
This is shaping a new consumption model, where e-commerce is becoming a full-fledged distribution channel for medical nutrition.
Opportunities for e-commerce platforms
Online platforms can take advantage of several strategic benefits.
1. Wider range. Unlike physical pharmacies with limited space, e-commerce allows you to offer a wide selection of formulas for different clinical needs: high-protein, high-calorie, lactose-free, fibre-enriched, etc.
2. Educational content. Articles, blogs, advisory materials, and expert recommendations increase consumer confidence and promote informed decision-making.
3. Personalisation. The use of recommendation algorithms based on purchase history allows for the offering of relevant products and the creation of customised sets.
4. Subscriptions and automatic orders. Since medical nutrition is often used for a long time, regular deliveries through a subscription model can provide a stable cash flow.
The role of pharmacy platforms
Traditional pharmacy chains in the UK are also actively investing in digital solutions. For them, medical nutrition is a strategic category for several reasons.
Firstly, these are products with relatively high added value. Secondly, they are often accompanied by recommendations from doctors or dieticians, which increases the level of trust in the pharmacy channel.
Online pharmacy platforms can combine sales with advisory support from pharmacists. This creates a competitive advantage over general marketplaces.
Regulatory features
In the UK, medical nutrition is subject to strict regulation. Products must meet safety standards and be clearly labelled as ‘foods for special medical purposes’. For e-commerce, this means the need for accurate descriptions of indications, composition and restrictions on use.
Platforms must ensure:
- accuracy of information;
- compliance with advertising standards;
- transparency of delivery and return conditions;
- protection of customers’ personal data.
Proper compliance with regulatory requirements builds trust in the brand and reduces legal risks.
Conclusion
The medical nutrition market in the UK is undergoing a period of rapid transformation. The combination of demographic changes, clinical need for nutritional support and the digitalisation of consumer habits is creating favourable conditions for the development of e-commerce and pharmacy platforms. Companies that can combine a wide range of products, expertise, technology and regulatory compliance will have a significant chance of taking a leading position in this promising segment.
